Zai Lab Ltd financial data

Symbol
ZLAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
4560 Jinke Road, Bldg. 1, 4 F, Pudong, Shanghai, China
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 356 % -47.7%
Quick Ratio 15.5 % -44.7%
Debt-to-equity 39.4 % +90.7%
Return On Equity -34.6 % +6.74%
Return On Assets -24.8 % +19.3%
Operating Margin -137 % +26.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 1.08B shares +10.8%
Entity Public Float 1.7B USD -37%
Common Stock, Value, Issued 7K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 989M shares +2.39%
Weighted Average Number of Shares Outstanding, Diluted 989M shares +2.39%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 102M USD +47.7%
Revenue from Contract with Customer, Excluding Assessed Tax 398M USD +49.1%
Cost of Revenue 108M USD +35.6%
Research and Development Expense 235M USD -11.8%
Operating Income (Loss) -282M USD +23%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -257M USD +23.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -257M USD +23.2%
Earnings Per Share, Basic -0.26 USD/shares +25.7%
Earnings Per Share, Diluted -0.26 USD/shares +25.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 450M USD -43.1%
Accounts Receivable, after Allowance for Credit Loss, Current 85.2M USD +43.9%
Inventory, Net 39.9M USD -11%
Assets, Current 1.05B USD +11.8%
Property, Plant and Equipment, Net 48M USD -10.7%
Operating Lease, Right-of-Use Asset 21.5M USD +44.8%
Intangible Assets, Net (Excluding Goodwill) 56M USD +318%
Assets 1.19B USD +14.4%
Accounts Payable, Current 101M USD -10.7%
Employee-related Liabilities, Current 30.2M USD -10.4%
Liabilities, Current 299M USD +47.4%
Operating Lease, Liability, Noncurrent 13.7M USD +70.4%
Other Liabilities, Noncurrent 325K USD 0%
Liabilities 345M USD +43.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 50.5M USD +34.3%
Retained Earnings (Accumulated Deficit) -2.45B USD -11.7%
Stockholders' Equity Attributable to Parent 841M USD +5.63%
Liabilities and Equity 1.19B USD +14.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -90.1M USD -30%
Net Cash Provided by (Used in) Financing Activities 47.5M USD
Net Cash Provided by (Used in) Investing Activities 3.29M USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 1.08B shares +10.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.4M USD +69.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 45K USD
Deferred Tax Assets, Valuation Allowance 395M USD +10.3%
Operating Lease, Liability 21.8M USD +43.6%
Depreciation 8.6M USD +2.38%
Payments to Acquire Property, Plant, and Equipment 974K USD -72.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -244M USD +24.3%
Lessee, Operating Lease, Liability, to be Paid 23.2M USD +48.4%
Property, Plant and Equipment, Gross 85.1M USD +1.44%
Operating Lease, Liability, Current 8.05M USD +13.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.99M USD -2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.61M USD +15.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.4M USD +204%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.73M USD +106%
Deferred Tax Assets, Operating Loss Carryforwards 321M USD +8.72%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.91M USD +254%
Amortization of Intangible Assets 700K USD +250%
Depreciation, Depletion and Amortization 3.01M USD +13.4%
Deferred Tax Assets, Net of Valuation Allowance 3.77M USD +33.3%
Share-based Payment Arrangement, Expense 70.7M USD -11.3%
Interest Expense 113K USD